News and Articles

Dr. Abass Alavi, a pioneering figure in the field of molecular imaging and nuclear medicine, and his wife Jane Alavi, made a $100,000 donation to our Foundation.

BAMF Alzheimer’s patient says he feels privileged to come here and adds, “Now I have a shot.”

David was the first person in the United States to receive a new experimental agent to treat pancreatic cancer.

FDA-approved treatment is available to those with Alzheimer’s Disease, but only in its earliest stage. We walk through the early signs to look for.

We’re taking a look back at 2024’s biggest milestones and accomplishments.

BAMF Health is creating a global destination for intelligence-based precision medicine through the construction of a comprehensive Theranostics center in downtown Detroit.

Kid Rock’s dad received treatment for prostate cancer at BAMF Health.

Jan says he had run out of treatment options for his metastatic prostate cancer, but what he heard when he came to BAMF was hope.

Newly published research details BAMF Health’s collaboration with the National Cancer Institute, Leidos Biomedical Research Inc., and Yale University on the Artificial Intelligence and Medical Imaging (AIMI) project.

BAMF Health will be a site for Radiopharma Theranostics’ clinical trial and will also be manufacturing 18F-RAD 101 for other trial sites.

In celebration of Nuclear Medicine Week, we’re highlighting our phenomenal team of technologists.

Partnership increases physician and patient participation in clinical trials